Peoples Bancorp Announces Cash Dividend
NEWTON, N.C., May 17, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Peoples Bancorp of North Carolina, Inc., Newton, NC (Nasdaq: PEBK) declared the Company’s regular cash dividend for the second quarter of 2024 in the amount of $0.19 per share. The second quarter cash dividend will be paid on June 14, 2024 to shareholders of record on June 3, 2024.
Shareholders are encouraged to enroll in the Company’s Dividend Reinvestment and Stock Purchase Plan. For details, contact Krissy Price at (828) 464-5620 or (800) 948-7195 or you may email any questions to our transfer agent, Broadridge Corporate Issuer Solutions, Inc. at [email protected].
Peoples Bank, the wholly-owned subsidiary of Peoples Bancorp of North Carolina, Inc. operates 17 banking offices entirely in North Carolina, with offices in Catawba, Alexander, Lincoln, Mecklenburg, Iredell and Wake Counties. The Bank also operates loan production offices in Lincoln, Mecklenburg, Rowan, and Forsyth Counties. The Company’s common stock is publicly traded and is quoted on the Nasdaq Global Market under the symbol “PEBK.”
Statements made in this press release, other than those concerning historical information, should be considered forward-looking statements pursuant to the safe harbor provisions of the Securities Exchange Act of 1934 and the Private Securities Litigation Act of 1995. These forward-looking statements are based on information currently available to management and are subject to various risks and uncertainties, including but not limited to those described in Peoples Bancorp of North Carolina, Inc.’s annual report on Form 10-K for the year ended December 31, 2023, under “General Description of Business” and otherwise in the Company’s reports and filings.
| Contact: | Lance A. Sellers |
| President and Chief Executive Officer | |
| Jeffrey N. Hooper | |
| Executive Vice President and Chief Financial Officer | |
| Phone 828-464-5620 |
Source: Peoples Bancorp of North Carolina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Go Tuck Yourself... In! Ryde: Canada Launches SLEEP to Help Canadians Fall Asleep Faster
- “Kevin Quinn: Hold Dexterra Accountable”: SEIU Local 2 holds rally outside TransLink office
- New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share